Vanda Pharmaceuticals
VNDA
₹407.53
Share price
-0.43%
Change (1 day)
-18.89%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) Fails to deliver data
Key failure to deliver metrics for Vanda Pharmaceuticals:
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: ₹0.22 M
- Last 3 months FTD volume: ₹0.52 M
- Last year FTD volume: ₹0.52 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Vanda Pharmaceuticals (VNDA) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Vanda Pharmaceuticals (VNDA) - since 2013
Volume in USD (price x number of shares), data since 2013Vanda Pharmaceuticals (VNDA) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | ₹0.83 M | -21.45% |
| 2024 | ₹1.05 M | -46.53% |
| 2023 | ₹1.98 M | 25.12% |
| 2022 | ₹1.58 M | -83.12% |
| 2021 | ₹9.37 M | 250.19% |
| 2020 | ₹2.67 M | 10.49% |
| 2019 | ₹2.42 M | -79.15% |
| 2018 | ₹11.62 M | 291.09% |
| 2017 | ₹2.97 M | -11.3% |
| 2016 | ₹3.34 M | -92.37% |
| 2015 | ₹43.92 M | 14.93% |
| 2014 | ₹38.22 M | 381.32% |
| 2013 | ₹7.94 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novartis NVS | ₹8.82 M | ₹0.15 B | 🇨🇭 Switzerland |
 Eli Lilly LLY | ₹37.29 M | ₹0.20 B | 🇺🇸 USA |
 Johnson & Johnson JNJ | ₹10.58 M | ₹0.12 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | ₹11.54 M | ₹0.26 B | 🇺🇸 USA |
 Pfizer PFE | ₹26.37 M | ₹0.27 B | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | ₹0.05 M | ₹1.27 M | 🇺🇸 USA |
 Merck MRK | ₹12.12 M | ₹0.17 B | 🇺🇸 USA |